Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01514 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM222B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZP761C1711 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
MICAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC6C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM109 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIFR-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on